Zacks Research Brokers Boost Earnings Estimates for Clorox

The Clorox Company (NYSE:CLX) – Equities research analysts at Zacks Research increased their Q4 2026 earnings per share estimates for shares of Clorox in a note issued to investors on Monday, February 17th. Zacks Research analyst R. Department now expects that the company will earn $2.18 per share for the quarter, up from their prior estimate of $1.90. The consensus estimate for Clorox’s current full-year earnings is $7.15 per share.

Clorox (NYSE:CLX) last issued its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the prior year, the business posted $2.16 earnings per share.

Several other equities analysts also recently weighed in on the company. Wells Fargo & Company raised their price objective on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 4th. Evercore ISI raised their price objective on Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Finally, Barclays raised their price objective on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research note on Wednesday, February 5th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $158.21.

Clorox Stock Performance

NYSE CLX opened at $152.93 on Thursday. Clorox has a 1-year low of $127.60 and a 1-year high of $171.37. The company has a market capitalization of $18.84 billion, a P/E ratio of 41.78, a PEG ratio of 2.54 and a beta of 0.42. The business has a 50 day moving average price of $158.11 and a 200 day moving average price of $159.68. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60.

Institutional Investors Weigh In On Clorox

Several hedge funds have recently made changes to their positions in CLX. Wealth Group Ltd. acquired a new stake in shares of Clorox during the third quarter worth $231,000. Creative Planning boosted its holdings in shares of Clorox by 7.4% during the third quarter. Creative Planning now owns 29,089 shares of the company’s stock worth $4,739,000 after purchasing an additional 1,996 shares during the last quarter. Blue Trust Inc. boosted its holdings in shares of Clorox by 34.7% during the third quarter. Blue Trust Inc. now owns 913 shares of the company’s stock worth $149,000 after purchasing an additional 235 shares during the last quarter. Sequoia Financial Advisors LLC boosted its holdings in shares of Clorox by 2.5% during the third quarter. Sequoia Financial Advisors LLC now owns 4,228 shares of the company’s stock worth $689,000 after purchasing an additional 102 shares during the last quarter. Finally, Eastern Bank acquired a new position in Clorox in the third quarter valued at $1,027,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.